Skip to content

MR- versus CT-guided biopsy of liver lesions <2 cm to optimize hit rate. - MR. CORRECT trial

MR- versus CT-guided biopsy of liver lesions <2 cm to optimize hit rate. - MR. CORRECT trial - MR. CORRECT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00032070
Enrollment
147
Registered
2023-11-16
Start date
2023-12-07
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C22.0 C78.7

Interventions

Group 1: The randomization list is kept at the study center of the Department of Radiology. The procedure will be performed during an inpatient stay or on an outpatient basis. 1st intervention arm (go

Sponsors

LMU München
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Clinical indication for image-guided liver biopsy. The indication for image-guided intervention in this case must be independent of the study presented. - Maximum focal size 2 cm - No contraindication to MRI examination or CT examination with the respective contrast agent. - Platelets >50,000/mm3 (50 GPt/l) - PTT-INR/PTT 18 years

Exclusion criteria

Exclusion criteria: - Lack of consent and/or lack of capacity to consent to the study. - Contraindications for an MRI examination, especially implants not suitable for MR, tattoos or piercings, limiting claustrophobia - Contraindications for a CT examination - Contraindications for contrast media: o Known allergy to MR or CT contrast agents. o Higher grade renal insufficiency (GFR 1.5 times upper normal value o Presence of a coagulation abnormality

Design outcomes

Primary

MeasureTime frame
Recording of the clinical success rate (hit rate) of the liver lesion demonstrated either by the positive result in the histopathological examination of the punch biopsy (correlating to the known tumor entity) or by a confirmation of the negative result in the histopathological examination by the imaging result in the follow-up MRI examination after 3 months.

Secondary

MeasureTime frame
- To assess the technical success rate of MR-guided biopsy compared to CT-guided biopsy. - To assess the complication rate of MR-guided biopsy compared to CT-guided biopsy. - Survey of the duration of the procedure in MR-guided biopsy compared to that under CT-guidance.

Countries

Germany

Contacts

Public ContactMax Seidensticker

LMU

Max.Seidensticker@med.uni-muenchen.de+4989440076642

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026